neuropsychopharmacology : official publication of the american college of neuropsychopharmacology2007Vol. 32pp. -
557
mh2007neuropsychopharmacologymaximizing
Abstract
The success of well-developed protocols has been limited in real-world practice, where even effective strategies have not been sufficient to meet patient needs in routine clinical care owing to Axis I and III comorbidities. The Sequenced Treatment Alternatives to Relieve Depression (STAR(*)D) trial …